2-(3-bromonaphthalen-2-yl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine

Catalog No. :
ACXETO825
CAS No. :
2639316-70-2
Molecular Formula :
C20H14BBrN2
Molecular Weight :
373.06

IUPAC Name:2-(3-bromonaphthalen-2-yl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine

2-(3-bromonaphthalen-2-yl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-bromonaphthalen-2-yl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine
IUPAC Name2-(3-bromonaphthalen-2-yl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine
Molecular FormulaC20H14BBrN2
Molecular Weight373.06
SMILESBrC1=CC2=C(C=C1B3NC4=C5C(N3)=CC=CC5=CC=C4)C=CC=C2
InChI KeyYLRXWBLMTMVJOT-UHFFFAOYSA-N
Synonym2-(3-Bromo-2-naphthalenyl)-2,3-dihydro-1H-naphtho[1,8-de]-1,3,2-diazaborine;1H-Naphtho[1,8-de]-1,3,2-diazaborine, 2-(3-bromo-2-naphthalenyl)-2,3-dihydro-;2-(3-Bromonaphthalen-2-yl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine
CAS No.2639316-70-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXETO825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRMJN620 route compound structure diagram
    ACRMJN6202973762-38-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXETO825 route product structure diagram
    ACXETO8252639316-70-2
Inquiry

2. ACXETO825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXETO825 route product structure diagram
    ACXETO8252639316-70-2
Inquiry

Comments (0)